PHARMACY

Health Net extends TRICARE coverage to Richmond, Va. RediClinics

BY Jenna Duncan

RANCHO CORDOVA, Calif. Health Net Federal Services has announced today that RediClinic’s network of retail-based healthcare clinics inside Wal-Mart stores in the Richmond, Va. area will provide coverage to TRICARE North beneficiaries beginning Nov. 1.

Health Net Federal Services’ president, Steve Tough, announced Health Net’s enthusiasm to work with RediClinic to provide TRICARE coverage, and RediClinic’s chief executive officer Web Golinkin also stated, “RediClinic is delighted that military families in the Greater Richmond area can now take advantage of the high-quality, affordable health care we offer in our nine Virginia locations. … We also look forward to continuing our discussions with Health Net Federal Services to enhance accessible health care for military personnel throughout the TRICARE North Region.”

RediClinic is staffed by trained and certified nurse practitioners who provide patients with a number of healthcare services such as wellness screenings, physicals examinations, preventive services and vaccinations. Patients can visit RediClinics days a week and walk-in patients are welcome.

There are nine RediClinics in the Richmond area and two of them, the Chester clinic and the Colonial Heights clinic, are located within minutes of the Fort Lee U.S. military base. Officials said that extending TRICARE coverage is particular important now that the military population is expecting to grow due to base realignments and closures.

For more information, visit www.rediclinic.com. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

McKesson reports earnings increase for Q2 2008

BY Jenna Duncan

SAN FRANCISCO McKesson Co. reported Wednesday that its earnings for second quarter 2008 which ended Sept. 30 totaled $26.6 billion, up 9 percent from $24.5 billion at the same time last year.

“We had a solid quarter, with a particularly strong performance from Distribution Solutions despite industry concerns about lower prescription trends,” John H. Hammergren, chairman and chief executive officer said in a statement. “In Technology Solutions, our second quarter operating profit was up 8 percent year-over-year, although we did begin to see some customers delay their purchasing decisions.”

Second-quarter diluted earnings were $1.17 per share, up 41 percent from 83 cents per diluted share last year. That total included 27 cents per share from a $76 million tax reserve release and five cents per share after sale of the 42 percent holdings of Verispan, the company reported. McKesson benefited from the sale of its specialty pharmacy business Distribution Solutions, a business within McKesson Specialty Care Solutions.

McKesson also said that its second-quarter earnings totals included $25 million in pre-tax share-based compensation expense, versus its pre-tax expense of $28 million one year ago.

The company said that projections for 2009 earnings were reported at $4.00 to $4.15 per diluted share.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

CVS completes tender for Longs Drugs acquisition

BY Antoinette Alexander

WOONSOCKET, R.I. CVS Caremark has successfully completed the subsequent offering period of its tender offer for all of the outstanding common stock of Longs Drug Stores, and expects to effect the merger on or about Oct. 30.

The subsequent offering period for the tender offer expired at 6 p.m., New York City time, on Oct. 28. A total of approximately 28,317,338 shares of Longs were tendered in the initial and subsequent offering periods of the offer, representing approximately 78.07 percent of the outstanding shares.

CVS expects to effect, without a vote or meeting of Longs’ stockholders, a short-form merger on or about Oct. 30 to complete the Longs acquisition.

In the merger, each of the remaining outstanding shares (other than any shares owned by CVS or its subsidiaries) will be converted into the right to receive the same $71.50 in cash per share, without interest, that was paid in the tender offer.

Following the merger, Longs’ common stock will cease to be traded on the New York Stock Exchange.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?